| [1] Wheeler LA, Manzanera AG, Bell SD, et al. Phase 2 multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma[J]. Neuro-Oncology, 2016,18(8):1137-1145.[2] Alexiou GA, Goussia A, Kyritsis AP, et al. Influence of glioma's multidrug resistance phenotype on 99mTc-tetrofosmin uptake[J]. Mol Imaging Biol, 2011, 13(2):348-351.[3] 蔡蓉, 张丽珍. DNA依赖蛋白激酶的研究新进展[J]. 医学综述, 2013, 19(7):1182-1185.[4] Liu S, Opiyo SO, Manthey K, et al. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress[J]. Nucleic Acids Res, 2012, 40(21):10780-10794.[5] Malewicz M, Kadkhodaei B, Kee N, et al. Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair[J]. Genes Dev, 2011, 25(19):2031-2040.[6] 廖琪, 崔满华. 干扰DNA-PK和CHK1表达对卵巢癌细胞辐射凋亡影响的研究[J]. 中国实验诊断学, 2013, 17(9):1569-1570.[7] Kemp MG, Sancar A. ATR kinase inhibition protects non-cycling cells from the lethal effects of DNA damage and transcription stress[J]. J Biol Chem, 2016, 291(17):9330-9342.[8] Tavecchio M, Munck JM, Cano C, et al. Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination[J]. Cancer Chemother Pharmacol, 2012, 69(1):155-164.[9] Zhuang W, Li B, Long L, et al. Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy[J]. Brain Res, 2011, 1371:7-15.[10] Stronach EA, Chen M, Maginn EN, et al. DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance[J]. Neoplasia, 2011, 13(11):1069-1080.[11] Yoon JH, Ahn SG, Lee BH, et al. Role of autophagy in chemoresistance:Regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1[J]. Biochem Pharmacol, 2012, 83(6):747-757.[12] Munoz JL, Rodriguez-Cruz V, Greco SJ, et al. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells[J]. Mol Cancer Ther, 2014, 13(10):2399-2411.[13] Sakata S, Fujiwara M, Ohtsuka K, et al. ATP-binding cassette transporters in primary central nervous system lymphoma:decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells[J]. Oncol Rep, 2011, 25(2):333-339.[14] 隋华, 付晓伶, 潘树芳, 等. PI3K/Akt/NF-κB通路调控ABCB1/P-gp介导的人结肠癌细胞多药耐药的研究[J]. 中国癌症杂志, 2014, 24(2):106-111.[15] Song L, Xiong H, Li J, et al. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer[J]. Clin Cancer Res, 2011, 17(7):1839-1849.[16] 李修明.基于DC-CIK细胞免疫治疗联合化疗治疗晚期消化道肿瘤的临床疗效分析[J]. 中国实用内科杂志,2015,35(增1):119-121. |
